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Documentation of maternal uniparental disomy of chromosome 7 in 10% of patients with Russell-Silver syndrome
(RSS), characterized by prenatal and postnatal growth retardation and dysmorphic features, has suggested the
presence of an imprinted gene on chromosome 7 whose mutation is responsible for the RSS phenotype. Human
GRB10 on chromosome 7, a homologue of the mouse imprinted gene Grb10, is a candidate, because GRB10 has
a suppressive effect on growth, through its interaction with either the IGF-I receptor or the GH receptor, and two
patients with RSS were shown to have a maternally derived duplication of 7p11-p13, encompassing GRB10. In
the present study, we first demonstrated that the GRB10 gene is also monoallelically expressed in human fetal brain
tissues and is transcribed from the maternally derived allele in somatic-cell hybrids. Hence, human GRB10 is
imprinted. A mutation analysis of GRB10 in 58 unrelated patients with RSS identified, within the N-terminal
domain of the protein, a P95S substitution in two patients with RSS. In these two cases, the mutant allele was
inherited from the mother. The fact that monoallelic GRB10 expression was observed from the maternal allele in
this study suggests but does not prove that these maternally transmitted mutant alleles contribute to the RSS
phenotype.
Russell-Silver syndrome (RSS [MIM 180860]) is char-
acterized by prenatal and postnatal growth retardation
accompanied by dysmorphic features, such as triangular
facies and fifth-finger clinodactyly (Silver et al. 1953;
Russell 1954; Price et al. 1999). On the basis of familial
occurrence (Robichaux et al. 1981; Duncan et al. 1990;
Teebi 1992; Al-Fifi et al. 1996) and occasional chro-
mosomal rearrangements (Christensen and Nielsen
1978; Wilson et al. 1985; Butler et al. 1988; Roback et
al. 1991; Ramirez-Duenas et al. 1992; Tamura et al.
1993; Schinzel et al. 1994; Rogan et al. 1996; Egger-
mann et al. 1998; Monk et al. 2000), a genetic etiology
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for RSS has been suggested. However, the gene respon-
sible for RSS has not yet been identified.
The recent discovery of maternal uniparental disomy
of chromosome 7 [mUPD7] in 10% of patients with RSS
has suggested the presence, on chromosome 7, of an
imprinted gene whose mutation is responsible for the
RSS phenotype (Kotzot et al. 1995; Eggermann et al.
1997; Preece et al. 1997; Bernard et al. 1999). The pre-
dicted function of this putative RSS gene is regulation
of growth, since prenatal and postnatal growth retar-
dation is the hallmark of RSS. Mutations in either a
maternally repressed (i.e., paternally expressed) gene or
a paternally repressed (i.e., maternally expressed) gene
could account for the RSS phenotype.
If we assume that the putative RSS gene is paternally
expressed, the gene would not be expressed in mUPD7
cells. Therefore, the predicted function of the putative
gene would be facilitation of growth. Loss-of-function
mutations in the gene, when transmitted paternally,
should lead to the RSS phenotype. The human PEG1
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(paternally expressed gene-1) gene on 7q31 was consid-
ered to be an excellent candidate gene, because (1) hu-
man PEG1 and mouse Peg1 are imprinted and are ex-
pressed from the paternal allele (Kobayashi et al. 1997;
Riesewijk et al. 1997) and (2) a loss-of-function muta-
tion in mouse Peg1, when paternally transmitted, is as-
sociated with severe growth retardation (Kaneko-Ishino
et al. 1995). However, analysis of PEG1 in 49 patients
with RSS did not reveal any mutations (Riesewijk et al.
1998).
Alternatively, we could assume that the putative RSS
gene is maternally expressed. In this scenario, the gene
would be expressed in excess in mUPD7 cells. Hence,
the predicted function of the putative RSS gene would
be suppression rather than facilitation of growth. A gain-
of-function mutation in such a gene, when transmitted
maternally, would contribute to the RSS phenotype. The
human growth factor receptor–bound protein 10/ma-
ternally expressed gene-1 (GRB10/MEG1) gene, on
7p11.2-p12 (Jerome et al. 1997), is considered to be a
prime candidate, because (1) mouse Grb10 is subject to
imprinting and is maternally expressed (Miyoshi et al.
1998), (2) maternal uniparental disomy of the proximal
region of mouse chromosome 11 encompassing Grb10
leads to prenatal growth retardation (Cattanach et al.
1998), and (3) in vitro studies indicate that, by inter-
acting with either the insulin-like growth factor I (IGF-
I) receptor (O’Neill et al. 1996; Morrione et al. 1997)
or the growth hormone receptor (Moutoussamy et al.
1998), GRB10 has a suppressive effect on growth.
Recent documentation of two patients with RSS who
had a maternally derived interstitial duplication of 7p11-
p13 encompassing GRB10 (Joyce et al. 1999; Monk et
al. 2000) further strengthens arguments for GRB10 in-
volvement in the pathogenesis of RSS. In the present
study, we determined whether human GRB10 is im-
printed, and we then screened 58 patients with RSS for
GRB10 mutations.
First, monoallelic expression of human GRB10 was
investigated by reverse transcriptase (RT)–PCR anal-
ysis with a primer pair designed to amplify across a
known G/A single-nucleotide polymorphism in exon
3 (Angrist et al. 1998). Human brain tissues for use
in this analysis were obtained from the Research Re-
source Bank (Tokyo), with permission of the Ethics
Committee at the National Center of Neurology and
Psychiatry. Total RNA was extracted from brain by
a commercial kit (QIAGEN) and was treated with
RNase-free DNase. Then, cDNA was directly syn-
thesized using the SuperScript II amplification kit
(GIBCO/BRL) with an oligo-dT primer. RT-PCR anal-
ysis was done with nested primer pairs GRB76 (5′-
GCAGAAGGAACCCATGGCTTTAG-3′) and GRB78
(5′-AGAGATGAGGTTCTAAACTGCTGGTC-3′) and
nested primer pairs GRB83 (5′-CATCCGTACTAC-
CAGGACAAGG-3′) and GRB44 (5′-TGACAGCG-
AGGATGTGCACAG-3′), which were designed on the
basis of the published cDNA sequence of human
GRB10 (GenBank accession number AF001534). Am-
plification was carried out in a 20-ml reaction volume
containing 1 ml of reverse-transcription product, 1 #
reaction buffer, 2.5 mM dNTP mix, 1.5 mM MgCl2,
10 nmol each primer, and 0.25 U of Taq Gold poly-
merase (PE Biosystems). Reaction conditions were de-
naturation at 95C for 10 min; followed by 20 cycles
at 95C for 60 s, at 58C for 45 s, and at 72C for
90 s; and then a final extension step at 72C for 10
min. A second round of PCR was performed under
the same PCR conditions, with 1/20 of the first re-
action product. The PCR products were directly se-
quenced by the dideoxy sequencing method (BigDye
Dideoxy sequencing kit; PE Biosystems). Five fetal
brain tissues (19–27 wk gestation), shown to be het-
erozygous for the G/A single-nucleotide polymor-
phisms within exon 3, were examined. Only one al-
lele—g in two samples and a in three samples—was
present in each of the five RT-PCR products (fig. 1A).
Therefore, human GRB10 is monoallelically ex-
pressed in the fetal brain.
The parental origin of the expressed allele of human
GRB10 was determined by our taking advantage of
the recent finding that imprinting of human genes is
maintained in human-rodent somatic hybrid cells (Ga-
briel et al. 1998). Somatic hybrid cells produced by
crossing CHO cells and human lymphocytes retaining
a single human chromosome 7 (GM10791 and
GM13302; Coriell Cell Repositories) were investi-
gated by RT-PCR and methylation-specific PCR (Her-
man et al. 1996; Kosaki et al. 1997, in press; Kubota
et al. 1997). GM10791 and GM13302 carry a sin-
gle chromosome 7 and a derivative chromosome
der(7)t(7;17)(q36;q22), respectively (fig. 1B). Stan-
dard tissue-culture techniques were used to propagate
the hybrid cell lines according to the supplier’s rec-
ommendations, and genomic DNA and cDNA were
extracted from the cells by commercial kits (QIA-
GEN). Expression of PEG1, a human imprinted gene
on chromosome 7, known to be transcribed from the
paternal allele (Kobayashi et al. 1997; Riesewijk et
al. 1997; Kosaki et al. 2000), was evaluated by RT-
PCR with the primer pair PEG33 (5′-ATGGGATA-
ACGCGGCCATGGTG-3′) and PEG34 (5′-ATAGT-
GATGTGGTCTCGGTTTGTCACTG-3′) (Kosaki et
al. 2000). The cycling conditions were denaturation
at 95C for 10 min; followed by 40 cycles at 95C for
1 min, at 58C for 1 min, and at 72C for 2 min; and
then a final extension step at 72C for 10 min. PEG1
isoform 1 (Kosaki et al. 2000), the imprinted isoform,
was expressed in GM13302 but not in GM10791 (fig.
1C). Thus, the human chromosome 7 in the somatic
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Figure 1 Imprinting of the human GRB10 gene. A,Monoallelic
expression of human GRB10 in fetal brain. The genomic sequence of
a normal fetal tissue heterozygous for a G/A polymorphism in exon
3 (top) and the corresponding cDNA sequence (bottom). Note that
only the “A” allele is expressed in this sample. B, Determination of
the parental origin of the human chromosome 7 in somatic cell hybrids
GM10791 and GM13302, which carry a whole chromosome 7 and
a derivative chromosome der(7)t(7;17)(q36;q22), respectively: (1) both
hybrids harbor PEG1, as evidenced by positive amplification with
primer pair 5′-caatagtccacttcttacc-3′ and 5′-ggccgagatcttttaatc-3′ (Rie-
sewijk et al. 1998), corresponding to exon 6 of the human PEG1
genomic sequence; (2) expression of the imprinted PEG1 isoform 1
in GM10791, mUPD7 lymphoblastoid cell line GM11496, GM13302,
and a paternal upd(7) (pUPD7) lymphoblastoid cell line (Pan et al.
1998) analyzed by RT-PCR with GRB83 and GRB44, where PEG1 is
expressed in GM13302 and pUPD7 but not in GM10791 or mUPD7
and the housekeeping gene,HPRT, is used as a control; (3)methylation
status of the promoter of human PEG1 in each cell line, where genomic
DNA, treated with bisulfite, is amplified with PEGMF-PEGMR pair
and PEG1UF-PEG1UR, specific for the methylated and the unmethy-
lated allele, respectively, and the promoter is methylated in GM10791
and in mUPD7 but is unmethylated in GM13302 and pUPD7. Col-
lectively, the human chromosome 7 is paternally derived in GM13302
and maternally derived in GM10791. C, Expression of GRB10 in
GM10791 and GM13302, where (1) both hybrids harbor GRB10, as
evidenced by positive amplification, with primer pair GRB7 andGRB8,
and (2) GRB10 is expressed in GM10791, which carries a maternally
derived chromosome 7, but not in GM13302, which carries a pater-
nally derived chromosome 7.
hybrid cells was derived paternally in GM13302 and
maternally in GM10791.
To confirm this assignment of parental origin, the
methylation status of the CpG island in the human
PEG1 gene, which undergoes parent-of-origin–spe-
cific methylation (Kobayashi et al. 1997; Riesewijk et
al. 1997), was evaluated by methylation-specific PCR,
as described elsewhere (Kosaki et al., in press).
PEGMF (5′-TAGTTGCGTTTCGTAAGCGTAGTGT-
C-3′) and PEGMR (5′-ACACAATCCTCCGCTCGC-
CTA-3′) were used to amplify the methylated allele,
and PEG1UF (5′-GTGGTAGTTGTGTTTTGTAAGT-
GTAGTGTT-3′) and PEG1UR (5′-CACACAATCCT-
CCACTCACCTACA-3′) were used for the unmethy-
lated allele. In GM13302 the promoter of PEG1
isoform 1 (Kosaki et al. 2000), was exclusively un-
methylated, whereas in GM10791 the promoter was
exclusively methylated. Hence, expression of PEG1
and methylation of the promoter of PEG1 collectively
indicated that the human chromosome 7 was derived
paternally in GM13302 and maternally in GM10791.
Last, expression ofGRB10was evaluated by RT-PCR,
with the GRB83-GRB44 primers under PCR conditions
the same as those used for amplification of PEG1. A
GRB10 amplicon was present in GM10791, which con-
tains a maternally derived chromosome 7, but not in
GM13302, which contains a paternally derived chro-
mosome 7. Hence, it can be concluded that human
GRB10 is imprinted and expressed solely from the ma-
ternal allele.
After demonstrating maternal allele–specific expres-
sion, we undertook a mutation analysis of GRB10 in
two groups of patients with RSS, one from Japan and
the other from Europe. The first group consisted of 30
unrelated Japanese patients with RSS who fulfilled at
least three of the following diagnostic criteria (Price et
al. 1999): low birth weight (!2SD); short stature at
the time of diagnosis (!2SD); characteristic facial fea-
tures; and facial, limb, or trunk asymmetry. Clinical in-
formation and material for analysis were provided by
clinicians throughout Japan. Appropriate informed con-
sent was obtained from all subjects. Karyotypes were
normal, and mUPD7 was excluded by either genotyping
analysis or methylation analysis of PEG1 (Riesewijk et
al. 1997; Kosaki et al., in press). Cell lines from the
second group of patients with RSS were derived from
the European Collection of Cell Cultures. A total of 28
RSS cell lines deposited by Richard Trembath, who de-
fined the diagnostic criteria for RSS (Price et al. 1999),
were analyzed.
Using primers based on the reported genomic se-
quence of human GRB10 (GenBank accession numbers
AF073363–AF073378; Angrist et al. 1998), we ampli-
fied each of the 16 exons ofGRB10 from genomic DNA.
The PCR conditions were denaturation at 95C for 10
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Figure 2 Identification of the GRB10 mutation. Exon 3 of
GRB10 was amplified from genomic DNA of patients affected with
Russell-Silver syndrome. Two patients, RS1 and RS3, had a hetero-
zygous missense mutation (cctrtct, Pro95Ser) that was maternally de-
rived. Primers GRB7 and GRB8 were used. A, Automated sequencing
of the PCR products.B,Restriction enzyme digest of the PCRproducts.
The missense mutation ablates an Eco O-109 I site. The mutant allele
is demonstrated as a band at 267 bp.
min; followed by 35 cycles at 95C for 1 min, at 58C
for 1 min, and at 72C for 1 min; and a final extension
step at 72C for 10 min. The primer sequences can be
obtained from the corresponding author, on request.
PCR products were subjected to denaturing high-per-
formance liquid chromatography (WAVE; Transgen-
omic) (Liu et al. 1998; Wagner et al. 1999), and, when
abnormal chromatographic patterns were detected, the
PCR products were sequenced on an automated se-
quencer (ABI310; PE Biosystems).
The mutation analysis revealed that two patients with
RSS—RS1 and RS3—had a heterozygous CrT transi-
tion that was not present in 100 ethnically matched con-
trols (200 chromosomes) (fig. 2). The base change was
confirmed by EcoO109I digestion. This transition leads
to a prolinerserine substitution at codon 95 (P95S),
which is located in the amino-terminal region of GRB10.
Patient RS1, delivered at 39 wk gestation after an un-
eventful pregnancy, had a birth weight of 1.80 kg (3.5
SD) and a length of 42.5 cm (3.5 SD). At age 3.5 years,
her weight was 10.5 kg and her height was 86.5 cm
(both 3.5 SD). She had facial features that were char-
acteristic of RSS, including triangular facies, down-
turned corners of the mouth, and fifth-finger clinodac-
tyly. The P95S substitution was derived from the mother,
who had normal height (163 cm) and no features of
RSS. The unaffected mother received the mutant allele
from her father (i.e., the maternal grandfather). RS3,
who was unrelated to RS1 and was delivered at 39 wk
gestation after an uneventful pregnancy, had a birth
weight of 2.55 kg (2SD) and a length of 45.5 cm
(2SD). He had the same characteristic physical features
as patient RS1. The P95S substitution was derived from
his mother, who had a height of 153 cm (1SD). DNA
samples from the maternal grandparents were not
available.
Both the identification of the P95S substitution in the
proline-rich amino-terminal region of GRB10 in two of
58 patients with RSS and the absence of similar muta-
tions in 100 normal individuals suggest that the amino
acid substitution may result in functionally significant
change in the critical RSS-related gene on chromosome
7. The documented paternal origin of the mutated P95S
allele in the mother of patient RS1 is consistent with the
normal phenotype observed in this individual, in spite
of the inheritance of the mutant allele. Although she
possesses an allele with the samemutation as her affected
daughter, this paternally derived allele would not be ex-
pressed in the mother. Ultimately, direct assessment of
the effects of the mutation on the functional properties
of the GRB10 protein will be required in order to verify
their causal role in RSS.
Since GRB10 is a maternally expressed gene, it is ex-
pected to be overexpressed in patients with RSS who
have maternal UPD7 or maternally derived duplication
of 7p12 (Joyce et al. 1999; Monk et al. 2000). By anal-
ogy, the GRB10 mutations that we have identified are
likely to result in a gain of function of the GRB10 pro-
tein. Functional studies are warranted to evaluate how
the prolinerserine substitution actually affects the ac-
tivity of GRB10. Although several reports have provided
evidence for inhibitory effects of GRB10 on insulin, IGF-
I, and GH receptor signaling (O’Neill et al. 1996; Mor-
rione et al. 1997; Moutoussamy et al. 1998), a recent
study demonstrated positive growth-regulatory effects of
GRB10 in cultured fibroblasts (Wang et al. 1999). The
investigation of both the functional significance of the
GRB10 mutations that we have identified and their rel-
evance to growth failure in patients with RSS should
help to define the actions and physiological importance
of GRB10.
It is intriguing to note that the amino acid substitution
is present in the proline-rich amino-terminal region of
GRB10, which determines binding interactions with
SH3-domain–containing proteins (Wojcik et al. 1999).
Although amino acids corresponding precisely to P95
are not evident in mouse Grb10 (Ooi et al. 1995; Laviola
et al. 1997), the absence of sequence identity at this
position does not rule out a functionally significant effect
of the P95S mutation in humans. Indeed, multiple
known disease-causing substitutions have been identified
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involving amino acid residues that are not identical in
other homologous human and mouse genes.
In the present study, we have demonstrated GRB10
coding-sequence mutations in only a small subset of pa-
tients with RSS. Such a low prevalence of GRB10 mu-
tations is not unexpected, because the etiology of RSS
is most likely genetically heterogeneous (Wakeling et al.
1998). Studies have shown that the RSS phenotype is
associated not only with chromosome 7 abnormalities
but also with other chromosomal aberrations, including
balanced translocation involving 17q (Midro et al. 1993)
and deletion of 15q26-qter (Wilson et al. 1985; Rogan
et al. 1996).
It has been proposed that the RSS phenotype in pa-
tients with 15q26-qter deletions results from hemizy-
gosity for the IGF-I receptor (IGF1R) (Peoples et al.
1995; Siebler et al. 1995). Because GRB10 may nega-
tively regulate IGF-I receptor–mediated growth and mi-
togenesis (O’Neill et al. 1996; Morrione et al. 1997), it
is conceivable that overexpression of GRB10 (e.g.,
mUPD7 and duplication of 7p11-13) and haploinsuffi-
ciency of the IGF-I receptor (e.g., 15q deletion) would
confer a similar phenotype. Since hemizygosity for IGF-
1 also has been associated with a phenotype similar to
that of RSS (Woods et al. 1996), we suggest that loss-
of-function mutations in IGF1 or its receptor and, most
probably, gain-of-function mutations in GRB10, as a
negative modulator of the IGF-I receptor, all lead to a
common RSS phenotype. The documentation ofGRB10
mutations in two patients with RSS in this study fur-
ther supports the concept that defects in the insulin-
like growth-factor axis all lead to the common RSS
phenotype.
In addition to its effects on the IGF-I receptor–signal-
ing pathway, it recently has been shown that GRB10 can
associate with the growth hormone (GH) receptor and
inhibit transcription of a GH reporter gene (Moutous-
samy et al. 1998). This in vitro finding suggests that
GRB10 mutations may affect GH as well as IGF-I sig-
naling. Since some patients with RSS respond to GH
therapy and others do not (Stanhope et al. 1998), it will
be important ultimately to determine whether the pres-
ence of mutations in GRB10 correlates with the effec-
tiveness of GH therapy.
In summary, we have shown that the human GRB10
gene is subject to genomic imprinting. A mutation anal-
ysis of GRB10 in 58 unrelated patients with RSS iden-
tified two individuals with a P95S substitution in the
amino-terminal region of the GRB10 protein. In both
cases, the P95S mutant allele was inherited from the
mother. The fact that monoallelic GRB10 expression
was observed from the maternal allele in this study sug-
gests but does not prove that these maternally trans-
mitted mutant alleles may contribute to the RSS
phenotype.
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